Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) ...

JAMA study confirms that vaccines measurably alter menstrual cycle timing, offering direct evidence of neuroendocrine effects ...

Boosting vitamin B12 levels can protect against acute pancreatitis by energizing pancreatic cells and preventing tissue ...

Alcohol consumption poses a significant global health risk, contributing to numerous diseases and injuries, especially among ...

A shared neuroimmune pathway involving CRH, mast cells, and Th17 cells may underlie the link between psoriatic arthritis and ...

Obesity can lead to a chronic inflammatory state within the body. What drives this inflammation? Does inflammation, in turn, ...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that ...

President – herald Farirai Machivenyika-Senior Reporter GOVERNMENT is committed to the full operationalisation of the ...

Company advances SL-325 program with an IND filing expected in the third quarter of 2025 – – Cash balance of approximately $60.9 million as of March 31, 2025, expected to fund operations into 2027 – ...

PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global ...

The IMPACT trial reinforces the need to check for antiphospholipid syndrome in women after they experience stillbirth and is ...

为解决呼吸道病毒感染引发的过度炎症反应导致肺组织损伤这一关键问题，临沂大学等机构研究人员开展黄芪甲苷IV (AST IV)调控肺泡巨噬细胞 (AM)免疫应答机制研究。发现AST IV通过抑制Wnt/β-catenin通路降低促炎因子 ...